Free Anti-Golimumab

Free Anti-Golimumab
Detecting the development of Anti-drug antibodies (ADAs) against Golimumab in patients being treated with Golimumab for chronic autoimmune and inflammatory conditions

Therapeutic Drug Monitoring (TDM) is to optimize biologic treatment for an individual patient. AFIAS Free Anti-Golimumab can detect the presence of anti-drug antibodies against Golimumab, requiring only a small amount of human serum or whole blood, and delivering results in a mere 10 minutes. This allows physicians to verify the presence of anti-drug antibodies immediately before the next administration.

About Using Reagent

• Sample Types Whole blood, Serum
• Reaction Time 10 mins
  
• Detection Range 2-40 ng/mL
  
• Indication Quantitative determination of free antibodies against Golimumab including in human whole blood/serum
  

Click